VEGFA and age-related macular degeneration: There are currently four FDA-approved anti-VEGF therapies for the treatment of AMD: MacugenTM (pegaptanib sodium), LucentisTM (ranibizumab), EyleaTM (Aflibercept) and most recently, BeovuTM (Brolucizumab) [7].